RE: Fundamental XR launches Fundamental Touch for wireless haptics12 Oct 2025 16:53
FVRVS Limited ("FundamentalVR")
Valuation of holding: £3.6 million
Holding: 10.3% (before any dilution on exercise of share options)
In the first half of 2025, FundamentalVR reinforced its position as a market leader in immersive medical training technologies. FundamentalVR achieved a significant milestone in May 2025 when its flagship platform, Fundamental Surgery, was awarded Best Healthcare & Wellness Solution at the 2025 Auggie Awards. As one of the most recognised Augmented Reality and Virtual Reality industry awards, this award reflects both the quality and impact of FundamentalVR's solutions in transforming surgical training and education.
The award underscores the growing importance of immersive learning platforms within healthcare, particularly as hospitals, universities, and training bodies increasingly seek scalable and cost-effective methods of upskilling medical professionals. By combining virtual reality, haptics, and data-driven performance insights, Fundamental Surgery enables healthcare professionals to practice and refine skills in safe, repeatable environments, bridging the gap between traditional classroom learning and hands-on surgical experience. This value proposition continues to resonate strongly with healthcare providers globally.
Recognition at the Auggie Awards provides more than brand visibility - it also validates FundamentalVR's strategy of embedding extended reality (XR) technology within clinical education and training. Such industry recognition is expected to enhance credibility with institutional partners and strengthen FundamentalVR's ability to pursue new commercial agreements with leading healthcare providers, medical device manufacturers, and academic institutions. The Board believes that it also recognises FundamentalVR's competitive positioning against both established training providers and emerging technology entrants in the healthcare simulation space.
FundamentalVR remains focused on scaling its platform to address the growing global demand for healthcare training solutions, particularly as medical systems continue to face resource pressures and increasing patient complexity. With its innovative technology and expanding reputation, FundamentalVR is considered to be well positioned to capture further market share and deliver long-term value to stakeholders.
As at 30 June 2025, the unaudited fair value of Tern's shareholding in FundamentalVR remained steady at £3.6 million (31 December 2024: £3.6 million).
Sign In
Follow the stocks
